Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin
- PMID: 8225612
- PMCID: PMC281327
- DOI: 10.1128/iai.61.12.5388-5391.1993
Regulation of inflammation-primed activation of macrophages by two serum factors, vitamin D3-binding protein and albumin
Abstract
A very small amount (0.0005 to 0.001%) of an ammonium sulfate [50% saturated (NH4)2SO4]-precipitable protein fraction of alpha 2-globulin efficiently supported inflammation-primed activation of macrophages. This fraction contains vitamin D3-binding protein essential for macrophage activation. Comparative macrophage activation studies with fetal calf serum, alpha 2-globulin fraction, 50% (NH4)2SO4 precipitate, and purified bovine vitamin D3-binding protein revealed that fetal calf serum and alpha 2-globulin fraction appear to contain an inhibitor for macrophage activation while ammonium sulfate precipitate contains no inhibitor. This inhibitor was found to be serum albumin. When bovine serum albumin (25 micrograms/ml) was added to a medium supplemented with 0.0005 to 0.05% (NH4)2SO4 precipitate or 1 to 10 ng of vitamin D3-binding protein per ml, activation of macrophages was inhibited.
Similar articles
-
Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.Immunology. 1991 Nov;74(3):420-4. Immunology. 1991. PMID: 1769691 Free PMC article.
-
Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.J Immunol. 1991 Jul 1;147(1):273-80. J Immunol. 1991. PMID: 2051023
-
Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.Immunol Cell Biol. 1993 Aug;71 ( Pt 4):249-57. doi: 10.1038/icb.1993.29. Immunol Cell Biol. 1993. PMID: 8225394
-
Therapeutic potential of vitamin D-binding protein.Trends Biotechnol. 2004 Jul;22(7):340-5. doi: 10.1016/j.tibtech.2004.05.001. Trends Biotechnol. 2004. PMID: 15245906 Review.
-
Neutrophil priming by cytokines and vitamin D binding protein (Gc-globulin): impact on C5a-mediated chemotaxis, degranulation and respiratory burst.Mol Immunol. 1999 Sep-Oct;36(13-14):885-92. doi: 10.1016/s0161-5890(99)00110-8. Mol Immunol. 1999. PMID: 10698343 Review.
Cited by
-
Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.Transl Oncol. 2008 Jul;1(2):65-72. doi: 10.1593/tlo.08106. Transl Oncol. 2008. PMID: 18633461 Free PMC article.
-
Potential role of GcMAF in suppressing the severity of COVID-19-induced immune responses: Lesson learned from HIV.Med Hypotheses. 2020 Nov;144:110293. doi: 10.1016/j.mehy.2020.110293. Epub 2020 Sep 24. Med Hypotheses. 2020. PMID: 33254486 Free PMC article. No abstract available.
-
Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein.Transl Psychiatry. 2018 Mar 13;8(1):61. doi: 10.1038/s41398-018-0109-7. Transl Psychiatry. 2018. PMID: 29531242 Free PMC article.
-
A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.Immunology. 1996 Aug;88(4):604-10. doi: 10.1046/j.1365-2567.1996.d01-684.x. Immunology. 1996. PMID: 8881764 Free PMC article.
-
Vitamin D receptor, vitamin D binding protein and CYP27B1 single nucleotide polymorphisms and susceptibility to viral infections in infants.Sci Rep. 2021 Jul 5;11(1):13835. doi: 10.1038/s41598-021-93243-3. Sci Rep. 2021. PMID: 34226633 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources